Employee login Common Ground Continuing Professional Development Cancer Symposium Oregon Nursing Research and Quality Employee login Common Ground Continuing Professional Development Cancer Symposium Oregon Nursing Research and Quality Home> Cancer Symposium 2017 Cancer Symposium Series at Salem Health Don’t miss this opportunity to meet with your colleagues and earn CME credits! All topics will be held from 5:30 to 7 p.m. Salem Health campus, Building D, Creekside Dining Room To register, fill out the form below or call 503-814-1441. Register now: Thursday, Oct. 5 HPV Associated Oropharyngeal Cancer Michelle Berlin, MD, MPH, Oregon Health & Sciences University John Donovan, MD, Willamette ENT Jared Hiebert, MD, Willamette ENT Matt Kang, MD, Salem Health And save the date for these upcoming topics: Wednesday, Nov. 1 Optimal Treatment for Early Stage Prostate Cancer: Surgery vs. Radiation vs. Surveillance Nancy Reyes-Molyneux, MD, Salem Health Jaffer Bashey, MD, Willamette Urology Anju Ganesshapa, MD, Kaiser Permanente Note: If you don't see the registration form below, please click here. Continuing Medical Education Earn up to 4.5 AMA PRA Category 1 credits (1.5 per session). Target audience: Primary care providers and other interested clinical staff. Learning objectives: Recognize the role of primary care in managing cancer patients and coordinating with cancer specialists. Become aware of current issues in cancer care including advances in screening, treatment options, and long-term effects of treatment. Learn how to use screening guidelines, shared decision making, and education resources to improve outcomes and the well-being of patients. Salem Health is accredited by the Oregon Medical Association to sponsor continuing medical education for physicians. Salem Health designates this live education activity for a maximum of 4.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. American Academy of Family Physicians credit pending approval.